GB2131693B - Composition for local corticotherapy containing hydrocortisone - Google Patents

Composition for local corticotherapy containing hydrocortisone

Info

Publication number
GB2131693B
GB2131693B GB08332805A GB8332805A GB2131693B GB 2131693 B GB2131693 B GB 2131693B GB 08332805 A GB08332805 A GB 08332805A GB 8332805 A GB8332805 A GB 8332805A GB 2131693 B GB2131693 B GB 2131693B
Authority
GB
United Kingdom
Prior art keywords
composition
containing hydrocortisone
corticotherapy
local
local corticotherapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08332805A
Other languages
English (en)
Other versions
GB2131693A (en
GB8332805D0 (en
Inventor
Braham Shroot
Foyer De Costil Carol Le
Liliane Ayache
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Publication of GB8332805D0 publication Critical patent/GB8332805D0/en
Publication of GB2131693A publication Critical patent/GB2131693A/en
Application granted granted Critical
Publication of GB2131693B publication Critical patent/GB2131693B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB08332805A 1982-12-09 1983-12-08 Composition for local corticotherapy containing hydrocortisone Expired GB2131693B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU84514A LU84514A1 (fr) 1982-12-09 1982-12-09 Composition stable pour corticotherapie locale contenant a l'etat solubilise de l'hydrocortisone

Publications (3)

Publication Number Publication Date
GB8332805D0 GB8332805D0 (en) 1984-01-18
GB2131693A GB2131693A (en) 1984-06-27
GB2131693B true GB2131693B (en) 1986-07-02

Family

ID=19729991

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08332805A Expired GB2131693B (en) 1982-12-09 1983-12-08 Composition for local corticotherapy containing hydrocortisone

Country Status (7)

Country Link
JP (1) JPS59112921A (de)
BE (1) BE898417A (de)
CH (1) CH658191A5 (de)
DE (1) DE3344437A1 (de)
FR (1) FR2537438B1 (de)
GB (1) GB2131693B (de)
LU (1) LU84514A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1223343B (it) * 1987-11-03 1990-09-19 Also Lab Sas Formulazioni farmaceutiche per somministrazione transdermica
EP0978574A1 (de) * 1998-08-04 2000-02-09 Nalco Chemical Company Zusammensetzungen von kationische Tenside und deren Verwendung als verschmutzungsverhindernde Substanzen für Gebläse mit erzwungenen Abzug
US20060018852A1 (en) 2003-08-22 2006-01-26 L'oreal Compositions containing topical active agents and pentylene glycol
US10851507B2 (en) 2017-12-11 2020-12-01 Pro-Tech Manufacturing And Distribution, Inc. Material pusher with floating coupler

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE673500C (de) * 1933-01-15 1939-03-23 Hoffmann La Roche & Co Akt Ges Verfahren zur Herstellung von haltbaren Loesungen schwer loeslicher Arzneimittel
NL6610468A (de) * 1965-08-03 1967-02-06
FR2314731A1 (fr) * 1975-06-19 1977-01-14 Nelson Res & Dev Azacycloalcan-2-ones 1-substituees et compositions pharmaceutiques contenant ces composes a titre d'excipients
US4082881A (en) * 1976-12-23 1978-04-04 E. R. Squibb & Sons, Inc. Topical and other type pharmaceutical formulations containing isosorbide carrier
SE8004580L (sv) * 1980-06-19 1981-12-20 Draco Ab Farmaceutisk beredning

Also Published As

Publication number Publication date
GB2131693A (en) 1984-06-27
CH658191A5 (fr) 1986-10-31
JPS59112921A (ja) 1984-06-29
FR2537438A1 (fr) 1984-06-15
JPH034044B2 (de) 1991-01-22
LU84514A1 (fr) 1984-10-22
DE3344437C2 (de) 1991-04-04
FR2537438B1 (fr) 1985-11-22
DE3344437A1 (de) 1984-06-14
BE898417A (fr) 1984-06-08
GB8332805D0 (en) 1984-01-18

Similar Documents

Publication Publication Date Title
DE3368198D1 (en) Composition for reducing weight
GB8305558D0 (en) Steroid compounds
DE3369999D1 (en) Photopolymerizable composition
DE3370700D1 (en) Photosensitive composition
DE3372485D1 (en) Method for reinforcing perfluoroelestomer compositions
GB2131692B (en) Compositions for local corticotherapy
DE3361254D1 (en) Composition for demoistening surfaces
GB8302283D0 (en) Composition containing anthralin
BG42672A3 (en) Composition for capsules
PH19525A (en) Emulsion type composition for external use
GB2132212B (en) Photopolymerizable composition
DE3375729D1 (en) Composition for forming releasable film
GB8333561D0 (en) Preparing rubberasphalt composition
GB8316766D0 (en) Paint-finishing composition
GB8331526D0 (en) Anti-acne composition
GB8333745D0 (en) Photopolymerizable composition
GB8321167D0 (en) Composition of matter
GB8324200D0 (en) Composition
GB2127827B (en) Pregnane compounds
GB8309901D0 (en) Toner composition
GB2131693B (en) Composition for local corticotherapy containing hydrocortisone
IL70220A0 (en) Process for 1-oxa-beta-lactams
AU559481B2 (en) Composition containing
GB8305191D0 (en) Composition
DE3264800D1 (en) Composition for joints

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19921208